Literature DB >> 35637417

Conformational strains of pathogenic amyloid proteins in neurodegenerative diseases.

Dan Li1,2, Cong Liu3,4.   

Abstract

Amyloid proteins, which are considered 'villains' in many neurodegenerative diseases, form enigmatic pathological strains that underlie disease pathogenesis and progression. Recent technical advances in cryogenic electron microscopy and solid-state NMR spectroscopy have enabled the high-resolution structures of full-length amyloid fibrils to be determined, initiating an era in which we have the opportunity to gain atomic-level structural understanding of pathogenic protein aggregation in neurodegenerative diseases. In this Review, we aim to explain the clinicopathological heterogeneity of neurodegenerative diseases by considering the polymorphic structures of amyloid fibrils. We decipher the structural basis for the generation of fibril polymorphs, how the fibril polymorphs differ in different disease contexts and how conformational changes alter the pathology caused by amyloid proteins during disease progression. Finally, we evaluate how this knowledge might aid clinical diagnostic and therapeutic strategies to treat neurodegenerative diseases.
© 2022. Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35637417     DOI: 10.1038/s41583-022-00603-7

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   38.755


  138 in total

1.  Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions.

Authors:  Heidi Olzscha; Sonya M Schermann; Andreas C Woerner; Stefan Pinkert; Michael H Hecht; Gian G Tartaglia; Michele Vendruscolo; Manajit Hayer-Hartl; F Ulrich Hartl; R Martin Vabulas
Journal:  Cell       Date:  2011-01-07       Impact factor: 41.582

2.  Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane.

Authors:  Maarten F M Engel; Lucie Khemtémourian; Cécile C Kleijer; Hans J D Meeldijk; Jet Jacobs; Arie J Verkleij; Ben de Kruijff; J Antoinette Killian; Jo W M Höppener
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-11       Impact factor: 11.205

3.  Activation of microglial cells by beta-amyloid protein and interferon-gamma.

Authors:  L Meda; M A Cassatella; G I Szendrei; L Otvos; P Baron; M Villalba; D Ferrari; F Rossi
Journal:  Nature       Date:  1995-04-13       Impact factor: 49.962

4.  Direct three-dimensional visualization of membrane disruption by amyloid fibrils.

Authors:  Lilia Milanesi; Tania Sheynis; Wei-Feng Xue; Elena V Orlova; Andrew L Hellewell; Raz Jelinek; Eric W Hewitt; Sheena E Radford; Helen R Saibil
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

Review 5.  The amyloid state of proteins in human diseases.

Authors:  David Eisenberg; Mathias Jucker
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

6.  Cytosolic proteostasis through importing of misfolded proteins into mitochondria.

Authors:  Linhao Ruan; Chuankai Zhou; Erli Jin; Andrei Kucharavy; Ying Zhang; Zhihui Wen; Laurence Florens; Rong Li
Journal:  Nature       Date:  2017-03-01       Impact factor: 49.962

7.  Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo.

Authors:  Ilie-Cosmin Stancu; Niels Cremers; Hannah Vanrusselt; Julien Couturier; Alexandre Vanoosthuyse; Sofie Kessels; Chritica Lodder; Bert Brône; François Huaux; Jean-Noël Octave; Dick Terwel; Ilse Dewachter
Journal:  Acta Neuropathol       Date:  2019-02-05       Impact factor: 17.088

8.  The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration.

Authors:  Anne-Laure Mahul-Mellier; Johannes Burtscher; Niran Maharjan; Laura Weerens; Marie Croisier; Fabien Kuttler; Marion Leleu; Graham W Knott; Hilal A Lashuel
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-19       Impact factor: 11.205

Review 9.  Protein transmission in neurodegenerative disease.

Authors:  Chao Peng; John Q Trojanowski; Virginia M-Y Lee
Journal:  Nat Rev Neurol       Date:  2020-03-23       Impact factor: 44.711

10.  α-synuclein strains that cause distinct pathologies differentially inhibit proteasome.

Authors:  Genjiro Suzuki; Sei Imura; Masato Hosokawa; Ryu Katsumata; Takashi Nonaka; Shin-Ichi Hisanaga; Yasushi Saeki; Masato Hasegawa
Journal:  Elife       Date:  2020-07-22       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.